The potential of expression analysis using cDNA microarrays to address complex problems in a wide variety of biological contexts is now being realised.
INTRODUCTION
Expression analysis using DNA microarrays is rapidly becoming the method of choice for researchers wishing to identify differentially expressed transcripts in tissues of interest (for reviews see 1±3). However, for many researchers, such as developmental biologists, the requirement for large amounts of starting RNA, usually 10±100 mg of total RNA, frequently prohibits the analysis of speci®c structures or cells of interest. Several different approaches have been taken to address this issue. These fall primarily into two groups: either attempting to increase the¯uorescent signal output per molecule, such as the use of the dendrimer technology (4), tyramide signal ampli®cation (5) and amino-allyl labelling (6) ; or increasing the amount of target available for labelling through ampli®cation, such as TPEA (7), RAGE (8) , SMART-PCR (9) and in vitro transcription (IVT) (10±13).
Concerns arising from use of these technologies include reproducibility, reliability, conservation of differential expression, associated costs and ease of use. Here we describe a novel single primer ampli®cation (SPA) method for use with spotted microarrays that addresses each of these concerns. The ®rst steps in this protocol generate double-stranded cDNA, initially primed by a modi®ed oligo(dT) primer. A primer equivalent to the heel of the modi®ed oligo(dT) primer is then used to direct semi-linear Taq DNA polymerase ampli®cation. The protocol is essentially a modi®ed cycle sequencing reaction, familiar and accessible to the majority of molecular biologists.
MATERIALS AND METHODS

RNA extraction
Total RNA was extracted from adult female mouse liver and kidney (strain 3H1) using Trizol (Invitrogen) followed by a RNeasy midi kit (Qiagen) according to the manufacturer's instructions. The quantity and quality of RNA was assessed using a Bioanalyzer 2100 (Agilent). RNA samples were pooled and aliquoted to ensure technical comparisons would not represent differences in RNA source or quality.
Target preparation
Preparation of labelled target cDNA for hybridisation to microarray slides was carried out using one of three methods.
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Reverse transcriptase (RT) labelling. For the standard RT labelling method 100 mg of total RNA was heated for 10 min at 70°C in the presence of 4 mg oligo(dT 15 ) (total volume 24 ml). Samples were cooled to 42°C and 26 ml labelling reaction mixture added [10 ml 5Q RT buffer (BRL); 5 ml 0.1 M DTT (BRL); 25 mM dATP, dGTP and dTTP, 2.5 mM dCTP (Abgene); 1 mM Cy3 or Cy5-dCTP (APB); 2 ml RNase inhibitor; 400 U M-MLV II (Superscript II; BRL)]. Samples were incubated at 42°C for 4 h, with 200 U M-MLV II added each hour. Following ®rst-strand cDNA synthesis, 20 mg RNase A was added to each sample and incubated at 37°C for 20 min. Reactions were stopped by the addition of 5 ml 0.5 M EDTA.
Klenow labelling. For labelling of unampli®ed RNA using Klenow fragment, 20 mg total RNA was employed in ®rst-and second-strand synthesis reactions, employing the`cDNA synthesis system' (Roche, catalogue no. 1117831). Firststrand synthesis used oligo(dT) priming. Double-stranded cDNA samples were puri®ed using a PCR puri®cation kit (Qiagen) and eluted with 26 ml water. An aliquot of 5 ml was subjected to gel electrophoresis to con®rm quantity and quality. Samples were¯uorescently labelled using the genomic DNA protocol published online at http://cmgm. stanford.edu/pbrown/protocols/4_genomic.html. Brie¯y, a 21 ml sample was mixed with 20 ml random octamer oligonucleotides (Bioprime Kit; Invitrogen). Samples were heated to 90°C for 5 min and snap cooled on ice. An aliquot of 5 ml 10Q dNTP mix was added to each sample (1.2 mM each dATP, dGTP and dTTP, and 0.6 mM dCTP), followed by 3 ml Cy5-dCTP or Cy3-dCTP (1 mM stocks; Amersham). An aliquot of 1 ml high concentration Klenow fragment (40±50 U/ml) was added and the samples incubated at 37°C for 2 h. Reactions were stopped by the addition of 5 ml 0.5 M EDTA pH 8.0.
Single primer ampli®cation reactions. For production of SPA cDNA, 10 mg of total RNA was used in ®rst-and secondstrand synthesis reactions, again employing the`cDNA synthesis system' (Roche, catalogue no. 1117831). However, a modi®ed oligonucleotide replacing oligo(dT) (5¢-AAACGA-CGGCCAGTGAATTGTAATACGACTCACTATAGGCGC-TTTTTTTTTTTTTTTTV-3¢) was used to prime ®rst-strand synthesis. This oligonucleotide contains the T7 RNA polymerase promoter sequence. This was chosen as it represents a non-eukaryotic sequence. We also utilised the heel primer from the TPEA technique (7), with comparable results (data not shown).
After completion of second-strand synthesis, samples were puri®ed using a PCR puri®cation kit (Qiagen) and eluted with 100 ml water. This 100 ml sample was taken to represent 10 mg of starting RNA and dilutions representing 0.5±0.031 mg starting RNA were employed in the ampli®ca-tion step. The assumption of 100% recovery after cDNA synthesis and puri®cation is likely to overestimate the amount of RNA represented in each sample. Ampli®cation reactions were set up as follows. Aliquots of 10 ml 10Q PCR buffer (including a ®nal Mg 2+ concentration of 1.5 mM), 10 ml dNTPs at 2 mM concentration, 100 pmol HPLC puri®ed heel primer (5¢-CGGCCAGTGAATTGTAATACGACTCACTA-TAGGCG-3¢), 12.5 U Taq DNA polymerase (Abgene) and cDNA template were combined in water to 100 ml total volume. Reactions were placed in a tetrad thermocycler (MJ Research) and incubated at 94°C for 3 min, then subjected to 40 cycles of 94°C (1 min), 59°C (1 min) and 72°C (2 min). Samples were again puri®ed (Qiaquick PCR puri®cation kit; Qiagen) and labelled using the method described in the Klenow labelling section above.
Microarray construction
Microarrays were manufactured using CMT-GAPS II slides (Corning) with a MicroTAS arrayer (BioRobotics). PCR probe elements were manufactured from plates 17±32 of the NIA mouse developmental set (14) . PCR ampli®cations were performed incorporating 5 ml 10Q PCR buffer, 5 ml 2 mM dNTPs, 2.5 ml 10 mM each primer (5¢-CCAGTCACGACGT-TGTAAAACGAC-3¢ and 5¢-NH 2 -GTGTGGAATTGTGAG-CGGATAACAA-3¢), 0.125 ml HotStart Taq DNA polymerase (Qiagen), 37.5 ml 1:10 glycerol stock and water to 150 ml. PCR samples were incubated at 95°C for 10 min, then subjected to 30 cycles of 95°C for 1 min, 60°C for 2 min and 72°C for 7 min. A ®nal incubation step of 72°C for 10 min was carried out.
Ampli®cation reactions were then puri®ed using Multiscreen-PCR plates (Millipore) and eluted into 100 ml water. Two microlitres was subjected to agarose gel electrophoresis to determine quality and yield. Remaining sample was precipitated and resuspended in 25 ml arraying solution (150 mM sodium phosphate buffer pH 8.5, 0.001% sarkosyl). Samples were submitted for arraying if a single band was observed upon gel electrophoresis and a concentration between 250 and 500 ng/ml was obtained. Each EST probe was spotted on each slide in duplicate.
Microarray hybridisation
Following termination of the labelling reactions individual samples were mixed with the correctly labelled corresponding sample and passed through a nucleotide removal kit (Qiagen). Mouse Cot-1 DNA (10 mg) and 20 mg of T7-dT primer/ oligo(dA)/oligo(dT) (ampli®ed target/RT labelled target/ Klenow labelled target, respectively) were then added to the mixed sample. Sample volume was reduced to 10 ml using a speed vac (Heto) and mixed with 30 ml hybridisation solution to give a ®nal concentration of 50% formamide, 6Q SSC, 0.2% SDS. Samples were heated to 80°C for 5 min then placed at 42°C for 30 min to allow repeat blocking. Samples were brie¯y subjected to centrifugation and pipetted beneath coverslips onto microarray slides incubated on a hot block at 42°C. Microarrays were placed into hybridisation chambers (Corning), the end wells were ®lled with 10 ml hybridisation buffer and the chambers sealed. Microarrays were placed in a waterbath at 42°C overnight.
Microarray washing
Microarrays were removed from the hybridisation chambers and washed in 2Q SSC for 3 min; 0.1Q SSC, 0.1% SDS for 3 min; 0.1Q SSC for 3 min. Slides were dried by centrifugation for 5 min at 60 g and entered for scanning.
Data capture and analysis
Microarrays were scanned using an Affymetrix 428 scanner, producing a 16 bit tif ®le for each of the dyes used. The images were analysed and data quanti®ed using ImaGene 4.1 (BioDiscovery). During image processing, an automatic agging process was used to remove spots whose background-subtracted mean signal intensity was less than four times the standard deviation of the background pixel intensity. The cut-off level of four was chosen due to previous observations made with the hardware/software combination. This level was found to be most ef®cient at removing background level spots without¯agging genuine signal. Manual¯agging was also used to highlight spot irregularities such as dust, scratches and misaligned features. Data for each experiment were scaled for intensity using a least squares regression technique where each individual kidney data set was scaled against the mean of all kidney data sets and likewise for the liver data sets (Table 1) (15) . Data were then normalised using the robust scatter plot smoothing technique, lowess, with print tip scaling from the`Statistical Microarray Analysis' (16) library for statistical software package R (17) .
On-slide duplicates were averaged and ®ltered to removē agged data using GeneSpring (Silicon Genetics). Spots agged in one or more arrays were excluded from further analysis. Data were exported to R where differential genes were selected from each slide using the single slide method described by Newton et al. (18) . These lists of genes identi®ed as signi®cantly different on each slide were combined for the four slides within each target preparation methodology.
The reproducibility of the techniques was analysed by performing analysis of variance (ANOVA) on ®ltered datasets using SPSS.
RESULTS
Technique overview
SPA, as for IVT ampli®cation, relies upon the use of a modi®ed oligo(dT) primer to drive ®rst-strand cDNA synthesis. The complement to this primer is incorporated into every transcript following second-strand synthesis. A primer complementary to the speci®c oligo in the oligo(dT) sequence then binds to the denatured second-strand cDNA and drives ampli®cation by Taq DNA polymerase cycling extensions (similar to cycle sequencing).
Experimental design
We performed 30 dual hybridisation microarray experiments using adult mouse kidney and liver RNA in order to determine the effect of single primer ampli®cation on expression ratios obtained when compared to conventional labelling techniques 
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Nucleic Twenty dual hybridisations were then performed with reciprocal labelling reactions from distinct ampli®cations ( Table 1) . Figure 1 shows a schematic overview and representative microarray images for the three techniques.
Data analysis: reliability and utility
One of the primary concerns of researchers conducting ampli®cation for microarray analysis is the reproducibility associated with the ampli®cation step itself. To address this question self±self hybridisations derived from two independent SPA ampli®cations of both kidney and liver cDNA were characterised. The Pearson correlation coef®cients for these are r = 0.985 and r = 0.986 for kidney and liver, respectively. To determine whether target cDNA ampli®cation had affected our ability to reliably pro®le gene transcription in the kidney and liver RNA samples, based on comparison with data produced with labelled target produced using conventional methods, we employed two complementary analyses of the 28 relevant datasets. First, we utilised a statistical analysis of variance (ANOVA) to ascertain the major determinants of differences across all data sets. Secondly, we identi®ed differentially expressed genes observed in all data sets and determined the similarity between these sets of outliers across the three different target production and labelling techniques.
Analysis of variance (ANOVA). The Levene's homogeneity of variance test (19) is utilised to examine the distribution of the individual data sets and test for equality of variances within the set, an assumption necessary for ANOVA. Application of this test to a random subset of genes from our data set was found to be not signi®cant (throughout the ANOVA analysis signi®cance was tested at the 95% level). To test for differences between methodologies we performed ANOVA (using SPSS) on the log-transformed ratios for each hybridisation. We examined the variation arising from methodology, replicates, amount of starting material, colour swaps and cDNA synthesis.
Variation between the datasets grouped by the three methodologies was found to be signi®cant [ observed across all data sets. A Bonferroni test indicated that several of the cDNA syntheses used are different but these are not con®ned to any one method consistently.
Identi®cation of outliers.
Lists of outliers [cDNA spots with differential expression above the set threshold (see Materials and Methods)] were generated to ascertain the ability of each methodology to reproducibly identify outliers. The lists generated from each of the methodologies were in turn set as the benchmark and the ability of other methodologies to reproducibly identify this list was then determined (Fig. 2 ). These data demonstrate that the SPA procedure allows identi®cation of outliers as consistently as RT-based and Klenow-based labelling methods. A PubMed survey of known genes consistently identi®ed as outliers con®rmed relative expression differences highlighted by the microarray hybridisations ( Fig. 2 and additional material) .
DISCUSSION
SPA is a reproducible and reliable method of target ampli®-cation for differential gene expression screens using cDNA microarrays. Not only does it identify outlier genes as ef®ciently as conventional methods, but also does so employing as little starting material as 32 ng total RNA.
The small level of disparity observed between SPA and the other techniques examined during this study can, for the most part, be attributed to the initial cDNA synthesis step, at present an unavoidable step for all microarray analysis. The ampli®cation itself does not signi®cantly increase the overall variability above that encountered during cDNA synthesis. Indeed, self±self hybridisation of independent ampli®cations demonstrates this point quite clearly. Surprisingly, the amount of starting material was not found to be signi®cant within the SPA hybridisations. A priori, we would have expected reproducibility to diminish as starting material was reduced. The observation that it does not suggests that 30 ng does not represent the lower limit of this technique. Indeed, recent experiments utilising this technique suggest that outlier identi®cation may be possible using total RNA extracted from as few as 10 cells (Birgit Liss, University of Oxford, Oxford, UK, personal communication).
Our data also demonstrate that the ability to reproducibly identify outliers is undiminished in comparison to the other methods employed. The limitation for inclusion in the central grouping of Figure 2 (genes signi®cant in all methods) is that the differential expression must have been observed in all 28 hybridisations. Omission from the central grouping is for the most part the result of failure of a single hybridisation to identify a differential greater than the threshold set. By visual inspection of the raster plots in Figure 2 it is clear to see that outliers identi®ed by one technique are for the most part similarly coloured in the other two techniques, albeit below the 28 experiment detection threshold.
Although the ef®cacy of the SPA technique is apparent, the precise mechanism of ampli®cation is unclear. The ef®ciency with which target can be produced from a small amount of starting material indicates that a model based on a merely linear reaction involving synthesis of one antisense cDNA copy per molecule at each round of extension is untenable. Rather, it is more likely that a combination of priming from the incorporated heel primer at the 3¢ end of each cDNA molecule and mismatch priming at multiple sites transcriptome-wide results in levels of ampli®cation signi®cantly greater than linear, though falling short of the exponential levels associated with standard PCRs. Allied to this, Klenow labelling itself appears to possess a strand-switching function. First-strand cDNA labelled with Klenow recapitulates outlier identi®cation when hybridised to slides arrayed with aminolinked sense strand cDNAs (data not shown). This was also observed when using sense oligonucleotide arrays. This suggests that further`ampli®cation' occurs during the labelling step that not only increases signal, but also allows hybridisation to both sense and antisense strands. The data presented here also indicate the ef®cacy of incorporation of Cy dyes using Klenow fragment and random priming of ®rst-strand cDNA. The signal intensity routinely obtained with 20 mg of total RNA is at least equivalent to that observed with conventional direct incorporation by reverse transcriptase of 100 mg of total RNA. The analyses performed also con®rm that cDNA synthesis and labelling represent signi®cant causes of variation between identical RNA samples and reaf®rm the need for replicate hybridisations and, in the case of RT labelling, dye-swap replicates.
The experiments described here were performed on aliquots of total RNA that had previously been examined for high quality, e.g. absence of signi®cant degradation. In real world examples of the use of limiting tissue samples such quality control measures may be impossible. We have recently used the SPA technique on total RNA extracted from individual male and female embryonic mouse gonads, equivalent tõ 200 ng, and have reliably detected appropriate expression of tissue-speci®c control genes and highlighted several novel genes not previously ascribed a sexually dimorphic expression pattern in the developing gonad (L.Sith and A.Green®eld, manuscript in preparation).
In conclusion, the Taq-based SPA protocol described here has certain advantages over previously published techniques. The simplicity of the protocol, requiring no modi®cation, ligation or RNA ampli®cation steps, will appeal to researchers wishing to rapidly characterise differential gene expression using DNA microarrays in cases of limiting tissue availability. This especially applies to those researchers with no previous experience in microarray sample preparation, as many will be familiar with the similar cycle sequencing protocol. Due to the stable DNA-based nature of the technique this methodology will also lend itself well to high throughput analysis of multiple small tissue samples. Our primary aim was also to develop a technique for microarray sample preparation that addressed the sometimes prohibitive costs associated with other methodologies. The technique itself uses off-the-shelf reagents rather than requiring expensive kits and thus can be considered an attractive alternative for researchers with limited funds.
Additional material is available from www.mgu.har.mrc. ac.uk/microarray/ampli®cation. This includes the original tif image ®les generated from the 30 microarrays, the signal intensity results for each channel of each microarray and a detailed table of homologies associated with previously published expression data. (20) . These plots demonstrate the variability of the ratio for a gene across each of the approaches used. Genes with relatively higher expression in kidney compared to liver are shown in red, while genes with relatively higher expression in liver compared to kidney are displayed in green. An expanded version of this ®gure listing the accession numbers of individual genes is available at www.mgu.har.mrc.ac.uk/microarray/ampli®cation.
